Wockhardt Limited
WOCKPHARMA
शेयरों में रैंक
#4555
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
शेयर मूल्य
$20.75
मार्केट कैप
$3.37B
बदलाव (1 दिन)
-1.38%
बदलाव (1 वर्ष)
33.03%
देश
IN
व्यापार Wockhardt Limited (WOCKPHARMA)
श्रेणी
Healthcare
Wockhardt Limited (WOCKPHARMA) के लिए बकाया शेयरों की संख्या
June 2026 की स्थिति में बकाया शेयरों की संख्या: 162.49M
Wockhardt Limited की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी के वर्तमान बकाया शेयरों की संख्या 162.49M है। March 2024 के अंत में कंपनी के पास 144.25M बकाया शेयर थे। बकाया शेयरों की संख्या आमतौर पर शेयर स्प्लिट्स और शेयर बायबैक से प्रभावित होती है।
Wockhardt Limited (WOCKPHARMA) के लिए 2004 से 2026 तक बकाया शेयरों का इतिहास
प्रत्येक वर्ष के अंत में बकाया शेयर
| वर्ष | बकाया शेयर | परिवर्तन |
|---|---|---|
| 2026 (TTM) | 162.49M | 4.41% |
| 2025 | 155.63M | 7.89% |
| 2024 | 144.25M | 0.13% |
| 2023 | 144.06M | 19.50% |
| 2022 | 120.55M | 0.31% |
| 2021 | 120.19M | 0.03% |
| 2020 | 120.15M | 0.05% |
| 2019 | 120.09M | 8.60% |
| 2018 | 110.58M | 0.06% |
| 2017 | 110.51M | -0.60% |
| 2016 | 111.18M | -0.08% |
| 2015 | 111.27M | 0.20% |
| 2014 | 111.04M | -0.15% |
| 2013 | 111.21M | -6.35% |
| 2012 | 118.76M | 0.00% |
| 2011 | 118.76M | 0.00% |
| 2010 | 118.76M | 0.00% |
| 2008 | 118.76M | 0.00% |
| 2007 | 118.76M | 0.02% |
| 2006 | 118.74M | 0.24% |
| 2005 | 118.46M | 0.00% |
| 2004 | 118.46M | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के लिए बकाया शेयर
| कंपनी | बकाया शेयर | अंतर | देश |
|---|---|---|---|
| 445.06M | 173.90% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| 105.38M | -35.15% |
US
|
|
| - | - |
IT
|
